Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Calmark Sweden AB (publ) announces today that the Company has received an order from the distributor in Saudi Arabia, Ajlan & Bros Holding Group Abilitii, covering the Calmark Neo platform and bilirubin tests. The economic value of today's order is of minor importance, but it is important from a launch perspective.
"We are very happy for the order which shows that our distributor is keen to start the registering of our product as soon as possible," says Magdalena Tharaldsen, Director International Business Development at Calmark. "Ajlan & Bros is a well-established company with a solid organization that is now investing heavily in Life Science, which provides good conditions for a quick sales start when the registration is complete."
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
This disclosure contains information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 08-09-2022 16:30 CET.